WO2009076539A3 - Modulation of protein degradation and uses thereof - Google Patents
Modulation of protein degradation and uses thereof Download PDFInfo
- Publication number
- WO2009076539A3 WO2009076539A3 PCT/US2008/086447 US2008086447W WO2009076539A3 WO 2009076539 A3 WO2009076539 A3 WO 2009076539A3 US 2008086447 W US2008086447 W US 2008086447W WO 2009076539 A3 WO2009076539 A3 WO 2009076539A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulation
- protein degradation
- protein
- compounds
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/10—Protein-tyrosine kinases (2.7.10)
- C12Y207/10002—Non-specific protein-tyrosine kinase (2.7.10.2), i.e. spleen tyrosine kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
- G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A novel chemical mutagenesis strategy identifies multiple regions of protein proteolytic sites. This provides a new tool in identifying compounds or therapeutic agents, which modulate protein or peptide proteolysis. Identification of such compounds would be essential to treat a battery of diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1279807P | 2007-12-11 | 2007-12-11 | |
US61/012,798 | 2007-12-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009076539A2 WO2009076539A2 (en) | 2009-06-18 |
WO2009076539A3 true WO2009076539A3 (en) | 2009-09-03 |
Family
ID=40756120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/086447 WO2009076539A2 (en) | 2007-12-11 | 2008-12-11 | Modulation of protein degradation and uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009076539A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11614451B2 (en) | 2019-07-08 | 2023-03-28 | Alzeca Biosciences, LLC | Targeting ligands for tau pathology |
WO2021007232A1 (en) * | 2019-07-08 | 2021-01-14 | Alzeca Biosciences, LLC | Targeting ligands for tau pathology |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6818427B1 (en) * | 2000-10-27 | 2004-11-16 | Millennium Pharmaceuticals, Inc. | MEKK1 molecules and uses thereof |
WO2006005462A2 (en) * | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with tyrosine kinase wee 1 (wee1) |
-
2008
- 2008-12-11 WO PCT/US2008/086447 patent/WO2009076539A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6818427B1 (en) * | 2000-10-27 | 2004-11-16 | Millennium Pharmaceuticals, Inc. | MEKK1 molecules and uses thereof |
WO2006005462A2 (en) * | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with tyrosine kinase wee 1 (wee1) |
Non-Patent Citations (2)
Title |
---|
SMITH ET AL.: "Redundant Ubiquitin Ligase Activities Regulate Wee1 Degradation and Mitotic Entry.", CELL CYCLE, vol. 6, no. 22, 15 November 2007 (2007-11-15), pages 2795 - 2799 * |
SUN ET AL.: "Characterization of Maize (Zea mays L.) Wee1 and its Activity in Developing Endosperm", PROC NATL ACAD SCI USA, vol. 96, 1999, pages 4180 - 4185 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009076539A2 (en) | 2009-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005120539A3 (en) | Novel use of peptide compounds for treating pain in trigeminal neuralgia | |
WO2004024890A3 (en) | Metalloprotease activation of myostatin, and methods of modulating myostatin activity | |
MX2010008206A (en) | Methods and compositions using klotho-fgf fusion polypeptides. | |
WO2007008758A3 (en) | Methods for identifying agents and conditions that modulate neurogenesis | |
NZ598176A (en) | Disintegrin variants and pharmaceutical uses thereof | |
WO2006127900A3 (en) | Tl1a in the treatment of disease | |
EP2380591A3 (en) | Vaccine peptide combinations against cat allergy | |
WO2010054167A3 (en) | Limited proteolysis of cd2ap and progression of renal disease | |
ZAA200501395S (en) | Footwear and footwear uppers | |
WO2009051439A3 (en) | Method of identifying agents which modulate the activity of calcium-activated chloride channel | |
WO2006099610A3 (en) | Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy | |
WO2007089715A3 (en) | Method for treatment of neuropathic pain | |
MX362164B (en) | Treatment of degenerative joint disease. | |
WO2006074450A3 (en) | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases | |
WO2009076539A3 (en) | Modulation of protein degradation and uses thereof | |
DE602005013650D1 (en) | PROTEIN HYDROLYSATE FOR THE TREATMENT OF TIREDNESS | |
EP1941897A3 (en) | Dermatological compounds containing oligopeptides for increasing skin sensitivity and neuronal stimulus perception | |
WO2006091544A3 (en) | Methods and compositions for modulating calcium channels | |
NZ601647A (en) | Variant hhip1 protein and methods and uses thereof | |
WO2006096498A3 (en) | Regulation of runx1 for treatment of pain | |
WO2006127458A3 (en) | Novel chemical compounds | |
WO2007137301A8 (en) | Modulation of chrebp expression | |
WO2008005487A3 (en) | Peptide sequences for modulation of protein kinase c | |
WO2005004894A3 (en) | Methods for increasing cell and tissue viability | |
GB2450660A (en) | Peptide derived from colostrum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08859305 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08859305 Country of ref document: EP Kind code of ref document: A2 |